Portal de investigación
EFECTO SOBRE LA CAPACIDAD FUNCIONAL DEL TRATAMIENTO CON HIERRO INTRAVENOSO O HIERRO ORAL, COMPARADO CON PLACEBO, EN PACIENTES CON INSUFICIENCIA CARDIACA CON FRACCIÓN DE EYECCIÓN DEL VENTRÍCULO IZQUIERDO PRESERVADA Y ANEMIA FERROPÉNICA
Datos básicos
- Protocolo:
- PREFER-HF
- EUDRACT:
- 2016-003604-31
- NCT:
- Centro:
- HOSPITAL DE MANISES
- Año de incio:
- 2019
- Año de finalización:
- 2020
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
JOSE LUIS MORALES RULL
Resultados del Ensayo Clínico
Distal hereditary motor neuropathies: mutation spectrum and genotype-phenotype correlation.
Frasquet, Marina; (...); Lupo, Vincenzo
Article. 10.1111/ene.14700. 2021
Effect of the HLA-DQA1*05 allele on the efficacy of ustekinumab in patients with Crohn's Disease. Multicenter study based on the ENEIDA registry of GETECCU.
Guardiola Capon, J.; (...); Rodriguez-Moranta, F.
Meeting Abstract. 2024
Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial.
Santas E; (...); Núñez J
Article. 10.1002/ehf2.14630. 2023
Long-term persistence and safety of biological drugs in patients with Inflammatory Bowel Disease. Differences between women and men: SEXEII study of ENEIDA
Gargallo-Puyuelo, C.; (...); Gomollon, F.
Meeting Abstract. 2023
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain
Hernandez Camba, A.; (...); Barreiro, M.
Meeting Abstract. 10.1093/ecco-jcc/jjab076.312. 2021
Study design of Heart failure Events reduction with Remote Monitoring and eHealth Support (HERMeS).
Yun S; (...); Comín-Colet J
Article. 10.1002/ehf2.12962. 2020